- PEGs by Application
- PEGs by Structure
-
PEG Linkers
- >PROTAC Linker
- >Methoxy PEG (mPEG)
- >Amine(NH2) PEG
- >DSPE PEG
- >Thiol(SH) PEG
- >Maleimide(Mal) PEG
- >DBCO PEG
- >Azide(N3) PEG
- >Carboxylic Acid(COOH) PEG
- >Acrylate(AC) PEG
- >Cyanine (Cy) PEG
- >NHS ester PEG
- >Biotin PEG
- >Aldehyde (Ald/CHO)PEG
- >Other Lipid PEG
- >Fluorescent (FITC) PEG
- >Cholesterol PEG
- >Hydroxyl(OH) PEG
- >OPSS PEG
- >Acrylamide(ACA) PEG
- >Epoxide (EPO) PEG
- >Hydrazide (HZ) PEG
- >Boc/Fmoc PEG
- > Folic Acid(FA) PEG
- >Lipoic acid(LA) PEG
- >Halide (F,Cl,Br,I) PEG
- >Methacrylate (MA) PEG
- >Rhodamine B(RB) PEG
- >Silane PEG
- >PLGA PEG
- >PCL PEG
- >PLA PEG
- >PEG Sulfonic acid
- >PEG PFP ester
- >PEG TFP ester
- >Benzyl-PEG
- >Aminooxy PEG
- >Hydrocarbons PEG
- >Nitrophenyl Carbonate (NPC) PEG
- >DNP PEG
- >Other PEG
- PEG in mRNA Vaccines
- PEG Raw Material
- Large Scale PEGs
CatalogID: 11822 Purity: ≥95% CAS NO.: 1800414-71-4
-
CAS No.:
1800414-71-4 -
Synonyms:
Azido-PEG11-Amine
-
Purity:
≥95% -
MF:
C24H50N4O11 -
MW:
570.7 -
Recommended Storage Condition:
Store at -5°C,keep in dry and avoid sunlight. -
Uses:
Azido-PEG11-amine (CAS No. 1800414-71-4) is a monodispersed PEG derivative containing an amino group with an azide group. The azide group can react with alkyne, BCN, DBCO via Click Chemistry to yield a stable triazole linkage. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc.
Azido-PEG11-amine can function either as a heterobifunctional click chemistry crosslinker or as a homobifunctional carbonyl-reactive crosslinker.
Biopharma PEG offers a wide range of PEG products from lab to commercial scale in both non-GMP and GMP grades. Email at sales@biochempeg.com and start using a superior product for your next product R&D project.
References:
1. Engineering Protein Scaffolds as Programmable Cancer TherapeuticsKimmel, Blaise Russel. Northwestern University ProQuest Dissertations Publishing, 2021. 28768196.
2. Hao, Dake et al. “Extracellular Matrix Mimicking Nanofibrous Scaffolds Modified With Mesenchymal Stem Cell-Derived Extracellular Vesicles for Improved Vascularization.” Frontiers in bioengineering and biotechnology vol. 8 633. 25 Jun. 2020, doi:10.3389/fbioe.2020.00633
3. Joshi A, Kate S, Poon V, et al. Structure-based design of a heptavalent anthrax toxin inhibitor. Biomacromolecules. 2011;12(3):791-796. doi:10.1021/bm101396u
4. Detection of SK2 Channels on Hippocampal Neurons. Jamie L. Maciaszek University of Connecticut (2012) DigitalCommons@Uconn Master's Theses Paper 237 April 20, 2012. http://digitalcommons.uconn.edu/gs_theses/237

Cat.No:LP101002
Cat.No:HE007020
Cat.No:LP100057
Cat.No:LP096291
Cat.No:A88048
Cat.No:MD253253
Cat.No:MD253005